While GLS2 has been suggested to serve as a tumor suppressor by directly binding the Rac GTPase and promoting ferroptosis in hepatocellular carcinoma17,18, it has also been shown to be necessary for cancer progression as we and others have found that it is essential for the growth and survival of luminal subtype receptor-positive breast cancer cells9,19. Here, GLS2 is linked to neoplasm.